Since MMP-14 is abundant in GBM and not normal brain 13, 16-19, CLIO-ICT provides highly specific destruction of tumor vasculature and highly specific elimination of GBM tumor cells and GICs residing in the perivascular niche. The gene discussed is MMP14; the disease is glioblastoma.